20091 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#302Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#303Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#304Methods for enhancing the release and absorption of water insoluble active agents
#305Microparticles supporting cells and active substances
#306Systems for treating an opioid-induced adverse pharmacodynamic response
#307Embolization
#308Enzyme delivery systems and methods of preparation and use
#309Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
#310Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
#311Manufacture of multiple minicapsules
#312VACCINE FORMULATION OF MANNOSE COATED PEPTIDE PARTICLES
#313Opioid agonist formulations with releasable and sequestered antagonist
#314Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#315Pharmaceutical compositions for inhalation
#316Method of making particles for use in a pharmaceutical composition
#317Method for producing granules
#318Microsphere compositions, preparation method and applications thereof
#319PHARMACEUTICAL COMPOSITIONS OF LEVODOPA AND CARBIDOPA
#320Coating metal oxide particles
#321Modified release formulations containing drug—ion exchange resin complexes
#322Escalating dosing regimen for effecting weight loss and treating obesity
#323Composition for controlled release of physiologically active substance
#324Core-shell particle formulation for delivering multiple therapeutic agents
#325Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
#326NUCLEIC ACID PARTICLES, METHODS AND USE THEREOF
#327Pharmaceutical Compositions
#328Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#329Formulation for the controlled release of one or several substances in the digestive tract of a mammal
#330PROCESSES FOR COATING A CARRIER WITH MICROPARTICLES
#331Granular Pharmaceutical Composition
#332CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#333Escalating dosing regimen for effecting weight loss and treating obesity
#334Reduced dose pharmaceutical compositions of fenofibrate
#335Active formulation for use in feed products
#336Risperidone microparticles formed by sublimation
#337Pharmaceutical composition
#338Encapsulated cells for hormone replacement therapy
#339Modified release formulations containing drug-ion exchange resin complexes
#340Immunomodulation using spores and pollen grains
#341Pharmaceutical formulation containing choline alfoscerate
#342CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#343Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#344Once daily formulations of tetracyclines
#345Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#346Method for production of particles of pharmaceutical substances and the use thereof
#347Modified release formulations containing drug-ion exchange resin complexes
#348Method for production of particles of pharmaceutical substances and the use thereof
#349Modified release formulations containing drug-ion exchange resin complexes
#350Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#351Combination and composition for treating obesity
#352Opiod agonist formulations with releasable and sequestered antagonist
#353Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#354Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#355Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
#356Immunomodulatory compositions
#357MICELLE COMPOSITIONS AND METHODS FOR THEIR USE
#358Cross-linked polymer particles
#359Non-abusable pharmaceutical composition comprising opioids
#360Non-abusable pharmaceutical composition comprising opioids
#361Microemulsions with adsorbed macromolecules and microparticles
#362Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#363PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#364Nanocell Drug Delivery System
#365Bioresorbable nonlamellar microparticles and uses thereof
#366Modified release formulations containing drug-ion exchange resin complexes
#367Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
#368GASTRIC ACID SECRETION INHIBITING COMPOSITION
#369Pharmaceutical composition
#370Opioid agonist formulations with releasable and sequestered antagonist
#371Embolization
#372RAPIDLY DISPERSING GRANULES, ORALLY DISINTEGRATING TABLETS AND METHODS
#373BARRIER COMPOSITION
#374METHOD FOR MANUFACTURING A SILICA POWDER COATED WITH AN ANTIBACTERIAL AGENT, AND TOPICAL DERMATOLOGICAL COMPOSITION INCLUDING THE SAME
#375VACCINE FORMULATION OF MANNOSE COATED PEPTIDE PARTICLES
#376Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#377Pharmaceutical compositions for the deterrence and/or prevention of abuse
#378Pharmaceutical Compositions
#379Enzyme Delivery Systems and Methods of Preparation and Use
#380Compositions and methods for delivery of frozen particle adhesives
#381Gastric Acid Secretion Inhibiting Composition
#382Biodegradable immunomodulatory formulations and methods for use thereof
#383MATERIAL AND PROCESS FOR INCORPORATION OF LOW DOSAGE ACTIVE PHARMACEUTICAL INGREDIENTS AND USE THEREOF
#384Method for treating hyperglycemia
#385Pharmaceutical Compositions
#386Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#387Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#388Enzyme delivery systems and methods of preparation and use
#389Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#390Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
#391Modified release formulations containing drug-ion exchange resin complexes
#392Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances
#393Once daily formulations of tetracyclines
#394TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES
#395PHARMACEUTICAL FORMULATIONS COMPRISING METFORMIN AND A FIBRATE, AND PROCESSES FOR OBTAINING THEM
#396Functionalized Nano- and Micro-materials for Medical Therapies
#397Once daily formulations of tetracyclines
#398Once daily formulations of tetracyclines
#399RAPID-ACTING PHARMACEUTICAL COMPOSITION
#400Opioid agonist formulations with releasable and sequestered antagonist
#401Therapeutic calcium phosphate particles and methods of manufacture and use
#402ELICITING HCV-SPECIFIC ANTIBODIES
#403Methods for preparing pharmaceuticals by emulsion aggregation processes
#404Granular compositions of magnesium oxide and citric acid and uses thereof
#405Gastric acid secretion inhibiting composition
#406Fluorescent ink compositions comprising functionalized fluorescent nanocrystals
#407Fast dissolving/disintegrating coating compositions
#408Pharmaceutical formulation comprising a water-insoluble active agent
#409Methods for enhancing the release and absorption of water insoluble active agents
#410Manufacture of multiple minicapsules
#411FORMULATIONS OF FLIBANSERIN
#412Biodegradable immunomodulatory formulations and methods for use thereof
#413Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#414Coated Pharmaceutical Compositions
#415Pharmaceutical formulation containing choline alfoscerate
#416Nanocell Drug Delivery System
#417Immunomodulatory compositions, formulations, and methods for use thereof
#418IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF
#419Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#420NANOCELL DRUG DELIVERY SYSTEM
#421Enzyme delivery systems and methods of preparation and use
#422Method of drug formulation of compositions comprising crystalline microparticle surfaces
#423Compositions of particulate coformulation
#424Embolization
#425Method of making particles for use in a pharmaceutical composition
#426Processes for coating a carrier with microparticles
#427Micronized tanaproget, compositions, and methods of preparing the same
#428CONTROLLED RELEASE COMPOSITION AND PREPARATION THEREOF
#429Matrix-based pulse release pharmaceutical formulation
#430Modified release formulations containing drug-ion exchange resin complexes
#431Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof
#432Gastric acid secretion inhibiting composition
#433Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#434NOVEL REDUCED DOSE PHARMACEUTICAL COMPOSITIONS OF FEXOFENADINE AND PSEUDOEPHEDRINE
#435Non-abusable pharmaceutical composition comprising opioids
#436TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#437Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
#438Compositions and methods for delivery of frozen particle adhesives
#439Compositions and methods for delivery of frozen particle adhesives
#440Abuse-Resistant Dosage Form
#441Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them
#442DELIVERY OF THERAPEUTIC COMPOUNDS VIA MICROPARTICLES OR MICROBUBBLES
#443PARTICLE FOR MEDICAL USE, PARTICLE FOR ANLAYSIS AND METHOD OF PRODUCING THE SAME
#444Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
#445preparation method of galactosyl-has magnetic nanoparticles containing adriamycin
#446USE OF MICROPARTICLES WITH ADSORBED ANTIGEN TO STIMULATE IMMUNE RESPONSES
#447POLYMER MATRIX, METHOD FOR ITS PRODUCTION, AND ITS USE
#448Granule and orally disintegrating tablet comprising oxycodone
#449CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#450NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS
#451Escalating dosing regimen for effecting weight loss and treating obesity
#452METHODS FOR DENDRITIC CELL THERAPY USING PHARMACOLOGICALLY ACTIVE MICROCARRIERS
#453TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
#454Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
#455SYSTEM AND COMPOSITION FOR DENDRITIC CELL THERAPY USING PHARMACOLOGICALLY ACTIVE MICROCARRIERS
#456METHODS OF TREATMENT WITH DRUG LOADED POLYMERIC MATERIALS
#457Cell Transport Compositions and Uses Thereof
#458Controlled release delivery device comprising an organosol coat
#459Process for the production of beadlets
#460Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
#461Porous Drug Delivery Devices and Related Methods
#462Pharmaceutical composition
#463COMPOSITIONS FORMULATED FOR SOLVENT-REGULATED DRUG RELEASE
#464PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME
#465Pharmaceutical compositions
#466Pharmaceutical composition
#467Intestinal absorptive anti-tumor agent
#468Pharmaceutical Compositions
#469Titanium Oxide Composite Particles, Dispersion Liquid Thereof, and Process for Producing Them
#470Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#471Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management
#472Compositions and Methods for Controlling Cholesterol Levels
#473Drug delivery vehicle that mimics viral properties
#474Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
#475Once daily formulations of tetracyclines
#476Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant
#477CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINTED RELEASE OF LOW-SOLUBILITY DRUG
#478Method for producing solid-lipid composite drug particles
#479Composite hydrogel drug delivery systems
#480Nanoparticles for Targeted Delivery of Active Agent
#481Pulmonary Formulation
#482GLUCAGON-LIKE PEPTIDE 1 (GLP-1) PHARMACEUTICAL FORMULATIONS
#483Controlled-release galantamine formulations
#484Multi-layer melatonin composition
#485Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
#486Production method of drug containing composite particle
#487Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
#488TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES
#489Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#490Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture
#491Cross-linked polymer particles
#492Pharmaceutical Compositions Useful in the Treatment of Pain
#493Temperature and pH sensitive copolymers
#494Microparticles
#495Drugs and gene carrier particles that rapidly move through mucous barriers
#496Compositions and Methods for Producing Vascular Occlusion Using a Solid-Phase Platelet Binding Agent
#497CO-BEADLET OF DHA AND ROSEMARY AND METHODS OF USE
#498Method for producing granules
#499Injectable microspheres for tissue construction
#500Bis(thiohydrazide amides) formulation
#501Eliciting HCV-specific antibodies
#502Polycationic Carbohydrates as Immunostimulants in Vaccines
#503Microparticles for Oral Delivery
#504Gastric acid secretion inhibiting composition
#505Microparticles for delivery of heterologous nucleic acids
#506Phenylephrine pharmaceutical formulations and compositions for colonic absorption
#507Pharmaceutical Formulations Comprising Metformin And A Fibrate, And Processes For Obtaining Them
#508Methods of treatment with drug loaded polymeric materials
#509Fibrin adhesive granulate and method for its preparation
#510Therapeutic calcium phosphate particles and methods of manufacture and use
#511Use of Microparticles for Antigen Delivery
#512Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#513Immunomodulatory formulations and methods for use thereof
#514Solid dispersion preparation
#515Particles for Inactivating Toxins
#516Salt and pH tunable resist patterns on polyelectrolyte multilayers
#517Sustained release matrix systems for highly soluble drugs
#518Modified release formulations containing drug-ion exchange resin complexes
#519Polypeptide films and methods
#520S/O Type Pharmaceutical Preparation and Method for Producing the Same
#521Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles
#522Polyamino acid-based insulin preparation
#523Microparticles
#524Antibiotic compositions
#525Polymer particles for delivery of macromolecules and methods of use
#526MODIFIED AND PULSATILE RELEASE PHARMACEUTICAL FORMULATIONS OF ESCITALOPRAM
#527Microemulsions with adsorbed macromolecules and microparticles
#528Method for production of bioresorable microparticles, microparticles thus obtained and use thereof
#529Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#530Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#531Nanocell drug delivery system
#532Gastric acid secretion inhibiting composition
#533Method
#534Gold surfaces coated with a thermostable chemically resistant polypeptide layer and applications thereof
#535Nanoparticles for delivery of a pharmacologically active agent
#536Coated tablets
#537Micronized tanaproget, compositions, and methods of preparing the same
#538Rapid-acting pharmaceutical composition
#539METHODS FOR IDENTIFICATION AND VERIFICATION
#540Complex of drug-carbon nanohorn and a process for producing the complex
#541Nanoparticle-based drug delivery system
#542Drug microparticles
#543Drug microparticles
#544Drug microparticles
#545Ceramic structures for prevention of drug diversion
#546Sustained release ionic conjugate
#547Compositions and methods for treating or preventing diseases of body passageways
#548Microparticle with cd28-specific monoclonal antibodies
#549Gastric acid secretion inhibiting composition
#550Linkage of agents using microparticles
#551Process for the produciton of cross-linked gelatin beadlets
#552Anti-angiogenic compositions and methods of use
#553Anti-angiogenic compositions and methods of use
#554Anti-angiogenic compositions and methods of use
#555Anti-angiogenic compositions and methods of use
#556Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object
#557Anti-angiogenic compositions and methods of use
#558METHOD FOR PRODUCING SOLID-LIPID COMPOSITE DRUG PARTICLES
#559Nonporous microparticle-prodrug conjugates for treatment of infection
#560Methods of treatment with drug loaded polymeric materials
#561Targeted and high density drug loaded polymeric materials
#562Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
#563Temperature and pH sensitive copolymers
#564Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances
#565Nanocell drug delivery system
#566Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof
#567Active agent transport systems
#568Immunotherapy compositions, method of making and method of use thereof
#569Polyamino acid-based insulin preparation
#570Modulators of the Notch signalling pathway and uses thereof in medical treatment
#571Microparticles for cell delivery
#572Abuse-safeguarded dosage form
#573Microparticles with adsorbent surfaces, methods of making same, and uses thereof
#574Embolization
#575Compositions and methods for treating or preventing diseases of body passageways
#576Microparticles with adsorbed polynucleotide-containing species
#577Method of manufacturing chemical-containing composite particles
#578Microparticles with adsorbent surfaces, methods of making same, and uses thereof
#579Abuse-proofed dosage form
#580Biodegradable targetable microparticle delivery system
#581Lipophilic-coated microparticle containing a protein drug and formulation comprising same
#582Co-beadlet of dha and rosemary and methods of use
#583Compositions and methods for treating or preventing diseases of body passageways
#584Microparticles supporting cells and active substances
#585Polymeric articles for carrying therapeutic agents
#586Sustained release compositions and controlled delivery method
#587Compositions and methods for treating or preventing diseases of body passageways
#588Microparticles
#589Compositions and methods for treating or preventing diseases of body passageways
#590Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
#591Compositions and methods for treating or preventing diseases of body passageways
#592Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino] pyrimidine trihydrochloride as active ingredient
#593Compositions and methods for treating or preventing diseases of body passageways
#594Antibiotic clarithromycin micropellet compositions
#595Sustained release ionic conjugate
#596Anti-angiogenic compositions and methods of use
#597Nucleic acid biomaterials and methods of formation and use
#598Pharmaceutical formulation comprising a water-insoluble active agent
#599Fruit-derived core-shell nanospheres
#600Nanodiamond compositions and their use for drug delivery